This is a preview of subscription content, log in via an institution to check access.
Reference
NICE. NICE draft guidance conditionally recommends elosulfase alfa (Vimizim) for treatment of very rare life-limiting genetic disorder. Media Release : 2 Sep 2015. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
Draft NICE guidance okays treatment for rare genetic disorder. PharmacoEcon Outcomes News 736, 27 (2015). https://doi.org/10.1007/s40274-015-2437-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2437-7